A brief summary of India's vaccine supply to the world
The Serum Institute of India has become the leading supplier to the World Health Organization ’s Covax facility. Besides Covax, SII has separate purchasing deals with several other governments across the world to supply the AstraZeneca/Oxford vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 24, 2021 Category: Pharmaceuticals Source Type: news

Glenmark gets USFDA nod for generic antipsychotic drug
The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, 100 mg, and 200 mg, Glenmark said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 24, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila reduces price of generic COVID-19 drug to Rs 899 per vial
Remdesivir is a critical drug in the treatment of COVID-19. This move to further revise the prices will go a long way in helping patients during these critical times, Zydus Cadila said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 24, 2021 Category: Pharmaceuticals Source Type: news

India delays big exports of AstraZeneca shot as infections surge, say sources
COVAX has so far received 17.7 million AstraZeneca doses from SII, of the 60.5 million doses India has shipped in total, and many countries are relying on the programme to immunise their citizens. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 24, 2021 Category: Pharmaceuticals Source Type: news

Pfizer begins early-stage study of oral drug to combat coronavirus
The drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's BioNTech SA, said the antiviral candidate showed potent activity against SARS-CoV-2, the virus that causes COVID-19, in lab studies. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 23, 2021 Category: Pharmaceuticals Source Type: news

Reputation of AstraZeneca's COVID vaccine marred by missteps
"The way they handled their data early on, AstraZeneca basically shot themselves in the foot," Julian Tang, a virologist at the University of Leicester, said even before the latest issue arose. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 23, 2021 Category: Pharmaceuticals Source Type: news

Kiran Mazumdar Shaw welcomes govt's decision to vaccinate all above the age of 45 from April 1
I am really pleased after hearing this important decision. I think that this is the time when we have to see how we can ensure that everyone gets atleast one vaccination shot. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 23, 2021 Category: Pharmaceuticals Source Type: news

Union govt reviews progress under National Health Mission
The NHM targets include reducing MMR to 1/1,000 live births, reducing IMR to 25/1,000 live births, reducing TFR to 2.1, bringing down prevalence of leprosy to less than 1 /10,000 population and incidence to zero in all districts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 23, 2021 Category: Pharmaceuticals Source Type: news

India to extend interval between Covishield vaccine doses to up to eight weeks
In a meeting last week, the experts decided to give flexibility up to 8 weeks for Covishield, a senior government official told ET. However, for the indigenously produced Covid-19 vaccine Covaxin, it decided to continue with the existing interval of 4-6 weeks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2021 Category: Pharmaceuticals Source Type: news

COVID Vaccination: India revises interval between 2 doses of Covishield, can be taken between 4-8 weeks
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 22, 2021 Category: Pharmaceuticals Source Type: news

India's Serum Institute to delay further vaccine shipments to Brazil, Morocco, Saudi: Source
The news comes as India, the world's biggest vaccine maker, is being criticised domestically for donating or selling more doses than inoculations conducted at home, despite reporting the most number of coronavirus infections after the United States and Brazil. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 21, 2021 Category: Pharmaceuticals Source Type: news

Prices of medicines to go up a tad; companies seek 20% jump
Prices of essential medicines including painkillers, antiinfectives, cardiac and antibiotics could go up marginally from April, with the government allowing drug makers an increase in line with the change in the annual Wholesale Price Index (WPI). The annual change in WPI notified by the government works out to 0.5% for 2020, the drug prices regulator National Pharmaceutical Pricing Authority said on Friday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 20, 2021 Category: Pharmaceuticals Source Type: news

Made-in-India Covaxin is hard to get in Bengaluru
Although demand for Bharat Biotech ’s Covaxin is high with many senior citizens preferring it over Covishield, there is very little information on where doses of the made-in-India vaccine are being administered. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 20, 2021 Category: Pharmaceuticals Source Type: news

CAIT alleges violation of Drugs & Cosmetics Act by e-pharmacies
"It is important to note that sale of prescription drugs and medicines through online medium is illegal. The legal regime, under the Drugs& Cosmetics Act, 1940, does not permit home delivery of prescription medicines for which a prescription "in original" is required," CAIT said in the letter to Goyal sent on Friday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 20, 2021 Category: Pharmaceuticals Source Type: news

Drug for spinal muscular atrophy disease already exempt from import duty: FM
Giving a clarification on the issue raised by Congress Vivek K Tankha during Zero Hour on March 17, Sitharaman in Rajya Sabha said the member had day before yesterday stated that there is one medicine to treat spinal muscular atrophy disease which costs about Rs 16 crore and there is a tax component at Rs 7 crore. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2021 Category: Pharmaceuticals Source Type: news

Will try to supply more doses of COVID-19 vaccine to UK later: Serum Institute
When contacted, a spokesperson for SII said, "Five million doses had been delivered a few weeks ago to the UK and we will try to supply more later, based on the current situation and requirement for the government immunisation programme in India". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2021 Category: Pharmaceuticals Source Type: news

RDIF, Stelis Biopharma partner to supply 200 mn doses of Sputnik V vaccine
Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and Hetero to make millions of doses of the vaccine, which has proven to be 91.6% effective against COVID-19. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2021 Category: Pharmaceuticals Source Type: news

Need to change Covaxin composition not felt yet due to vaccine's good efficacy against mutant variants: Government
Providing details of the efficacy rate of Covaxin and Covishield vaccines against each of the mutations, he said there was no significant difference noted in the efficacy of Bharat Biotech's Covaxin against the UK and the Brazil strains. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 19, 2021 Category: Pharmaceuticals Source Type: news

Health Ministry says no concern regarding Indian version of Oxford-AstraZeneca vaccine
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 18, 2021 Category: Pharmaceuticals Source Type: news

Coronavirus reinfections are rare, Danish researchers report
Prior infection with the coronavirus reduced the chances of a second bout by about 80% in people under 65, but only by about half in those older than 65. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 18, 2021 Category: Pharmaceuticals Source Type: news

Vaccine nationalism is threatening WHO ’s 2021 goal of 2 billion doses, says Adar Poonawalla
Many manufacturers, including Serum, already have missed timelines and commitments, Poonawalla said in an interview. It will take two to three months for shipments to Covax to really pick up, and reaching the 2021 target of 2 billion doses will be challenging, he said, predicting it will “spill over by a few months.” (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2021 Category: Pharmaceuticals Source Type: news

Blood clots in small number of AstraZeneca vaccine takers but no causative link found
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2021 Category: Pharmaceuticals Source Type: news

Omega Seiki joins hands with B Medical Systems for Covid vaccine storage boxes
"COVID-19 vaccine is a beacon of hope to millions of people in our country. The government has done its job by making it available free for distribution. Now it is our job to ensure it reaches the people in a completely safe way, across the country," Anglian Omega Group Chairman Uday Narang said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2021 Category: Pharmaceuticals Source Type: news

India says it has no concern about AstraZeneca vaccine side effects
​​The safety committee was also looking at "serious thromboembolic events" from the UK. Sweden and Latvia on Tuesday joined Spain, Germany, France, Italy, Netherlands, Ireland, Denmark, Iceland, and Norway in the suspension of the use of AstraZeneca's COVID-19 vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2021 Category: Pharmaceuticals Source Type: news

India not giving COVID vaccine to world at the expense of local population, asserts Harsh Vardhan
On the criticism that India is providing coronavirus vaccine to other countries when it is needed more at home, the minister asserted, "We are not giving (the vaccine) at the expense of our own people". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2021 Category: Pharmaceuticals Source Type: news

India's Gland Pharma to make up to 252 million Sputnik V vaccine doses
Sputnik V, developed by Moscow's Gamaleya Institute, has been approved in 22 countries, with the RDIF signing supply deals with over 13 countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2021 Category: Pharmaceuticals Source Type: news

Moderna begins study of COVID-19 vaccine in kids
Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2021 Category: Pharmaceuticals Source Type: news

Should you be concerned about blood clots, bleeding and AstraZeneca vaccine?
Blood clots and abnormal bleeding in a small number of vaccine recipients in European countries have cast doubt on its safety, although no causative link has been found between the patients ’ conditions and the vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2021 Category: Pharmaceuticals Source Type: news

Ocugen seeks to sell 100 million doses of Bharat Biotech's Covaxin in US in 2021
The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States. COVAXIN was shown to be 81% effective in an interim analysis of late-stage trial data on some 26,000 people in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2021 Category: Pharmaceuticals Source Type: news

French vaccine chief expects AstraZeneca's COVID-19 vaccine halt to be temporary
Germany, France and Italy said on Monday they would suspend AstraZeneca inoculations after several countries reported possible serious side-effects, but the World Health Organization said there was no proven link and people should not panic. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 16, 2021 Category: Pharmaceuticals Source Type: news

Strides Pharma arm receives USFDA nod for potassium chloride oral solution
Strides Pharma Global, Singapore, has received approval for Potassium Chloride for Oral Solution USP, 20 mEq from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

What you need to know about the coronavirus vaccine and side effects
Usually, when taking a vaccine for any disease, the human body tends to have a reaction to the shot, this is due to how vaccines are made - they are usually the inactive form of the disease they ’re trying to fight, this causes the body to fight back a bit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Covid-19 vaccine safe, based on scientific evidence, AstraZeneca reassures the world
It further said that, a review of available safety data of more than 17 million people vaccinated in the European Union (EU) and UK with its vaccine has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis (DVT) or thrombocytopenia, in any defined age group, gender, batch or in any particular country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Natco Pharma forays into pheromone-based technology for integrated pest management
"During Kharif 2021, NATCO plans to launch its first green label pheromone product for effective management of Pink Bollworm (PBW) in cotton crop, under its brand NATMATE PBW," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Over 3.17 crore coronavirus vaccine doses administered so far: Health Ministry
In its fight against the COVID-19 pandemic, India has crossed an important milestone of administering over 3.17 crore vaccine doses, the Union Health Ministry said on Monday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 15, 2021 Category: Pharmaceuticals Source Type: news

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market
As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used to treat chronic dry eye. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 14, 2021 Category: Pharmaceuticals Source Type: news

Over six COVID-19 vaccines in offing in India: Harsh Vardhan
"India has developed two vaccines, which have been given to 71 countries. Many more nations are seeking the vaccines, and these are not little-known nations...Canada, Brazil and other developed countries are using Indian vaccines with a great zeal," he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2021 Category: Pharmaceuticals Source Type: news

WHO insists AstraZeneca vaccine safe as jab faces new setbacks
The WHO, which said its vaccines advisory committee was examining the safety data coming in, Friday stressed that no causal link has been established between the AstraZeneca vaccine and clotting. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2021 Category: Pharmaceuticals Source Type: news

India reviews AstraZeneca side effects after concerns in Europe
New Delhi decided to conduct the review after several countries suspended rollout over blood clot fears even as the World Health Organization said there was no reason to stop using AstraZeneca's Covid-19 jab. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2021 Category: Pharmaceuticals Source Type: news

20 lakh jabs on Friday, highest so far: Govt
"India recorded a significant milestone in its countrywide COVID19 vaccination drive which started on January 16. More than 20 lakh (20,53,537) vaccine doses were given on Day-56 of the vaccination drive (March 12) through 30,561 sessions," the ministry said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2021 Category: Pharmaceuticals Source Type: news

COVID-19 vaccine-induced antibodies less effective against some coronavirus variants: Study
According to the scientists neutralising antibodies work by binding tightly to the virus and blocking it from entering cells, thus preventing infection. They said this binding only happens when the antibody's and the virus' shapes are perfectly matched to each other "like a key in a lock." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2021 Category: Pharmaceuticals Source Type: news

May not be new wave yet, vaccination plus Covid protocol key to quell surge in cases: Scientists
Rakesh Mishra, director of the CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), warned that there could be a new wave if the current trends continue and new homegrown variants of the virus may emerge. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 13, 2021 Category: Pharmaceuticals Source Type: news

Covid-19 vaccine: A shot at redemption for J & J?
J&J, which has vowed to sell the vaccine at cost, won approval Thursday from the European Union for its Covid-19 jab after receiving the green light earlier from regulators in the United States, Canada and South Africa. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

India to manufacture Johnson & Johnson ’s Covid-19 vaccine as part of Quad initiative
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

Pfizer, Moderna vaccines may greatly reduce risk of asymptomatic COVID-19 infection, study says
The Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries. An mRNA vaccine is based on the segments of the genetic material, or RNA, of the novel coronavirus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

Quad leaders set to roll out coronavirus vaccine initiative at historic summit
Prime Minister Narendra Modi will join US President Joe Biden, Australian Prime Minister Scott Morrison and Japanese Prime Minister Yoshihide Suga at the first summit of the Quad leaders which will be held virtually this evening. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

India imposes anti-dumping duty on Chinese antibacterial drug Ciprofloxacin Hydrochloride
India has imposed anti-dumping duty on the Chinese antibacterial drug Ciprofloxacin Hydrochloride to guard the domestic industry against cheap imports from the neighbouring country. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

Brazil gives final approval for AstraZeneca vaccine, sees domestic manufacture
The AstraZeneca vaccine is already being administered in Brazil, but is registered only for emergency use, and the doses have been imported from India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

WHO approves J & J's COVID-19 vaccine for emergency listing
It is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and AstraZeneca to receive backing from the WHO, and the first to be done in a single injection. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news

India to make billion-plus vaccine doses with US, Japan, Australia
The White House in a statement after a four-way summit announced support for a plan by Indian company Biological E Ltd. to "produce at least one billion doses of Covid-19 vaccines by the end of 2022. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 12, 2021 Category: Pharmaceuticals Source Type: news